Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Radiation Oncology Year : 2013

Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.

Enrique Chajon
  • Function : Correspondent author
  • PersonId : 942425

Connectez-vous pour contacter l'auteur
Guillaume Louvel
  • Function : Author
  • PersonId : 942426
Joël Castelli
Danièle Williaume
  • Function : Author
  • PersonId : 942428
Olivier Henry
  • Function : Author
  • PersonId : 942429
Elodie Vauléon
Jean-Pierre Manens
  • Function : Author
  • PersonId : 942432
Elisabeth Le Prisé
  • Function : Author
  • PersonId : 942433

Abstract

BACKGROUND: The objective was to analyze locoregional (LR) failure patterns in patients with head-and-neck cancer (HNC) treated using intensity-modulated radiotherapy (IMRT) with whole salivary gland-sparing: parotid (PG), submandibular (SMG), and accessory salivary glands represented by the oral cavity (OC). METHODS: Seventy consecutive patients with Stage I-II (23%) or III/IV (77%) HNC treated by definitive IMRT were included. For all LR failure patients, the FDG-PET and CT scans documenting recurrence were rigidly registered to the initial treatment planning CT. Failure volumes (Vf) were delineated based on clinical, radiological, and histological data. The percentage of Vf covered by 95% of the prescription isodose (Vf-V95) was analyzed. Failures were classified as "in-field" if Vf--V95 >= 95%, "marginal" if 20% < Vf-V95 < 95%, and "out-of-field" if Vf-V95 <=20%. Correlation between Vf-V95 and mean doses (Dmean) in the PG, SMG, and OC was assessed using Spearman's rank-order correlation test. The salivary gland dose impact on the LR recurrence risk was assessed by Cox analysis. RESULTS: The median follow-up was 20 months (6--35). Contralateral and ipsilateral PGs were spared in 98% and 54% of patients, respectively, and contralateral and ipsilateral SMG in 26% and 7%, respectively. The OC was spared to a dose <=40 Gy in 26 patients (37%). The 2-year LR control rate was 76.5%. One recurrence was "marginal", and 12 were "in-field". No recurrence was observed in vicinity of spared structures. Vf-V95 was not significantly correlated with Dmean in PG, SMG, and OC. The LR recurrence risk was not increased by lower Dmean in the salivary glands, but by T (p = 0.04) and N stages (p = 0.03). CONCLUSION: Over 92% of LR failures occurred "in-field" within the high dose region when using IMRT with a whole salivary gland-sparing strategy. Sparing SMG and OC in addition to PG thus appears a safe strategy.

Domains

Cancer
Fichier principal
Vignette du fichier
1748-717X-8-132.pdf (968.37 Ko) Télécharger le fichier
1748-717X-8-132.xml (67.11 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00833043 , version 1 (11-06-2013)

Identifiers

Cite

Enrique Chajon, Caroline Lafond, Guillaume Louvel, Joël Castelli, Danièle Williaume, et al.. Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.. Radiation Oncology, 2013, 8 (1), pp.132. ⟨10.1186/1748-717X-8-132⟩. ⟨inserm-00833043⟩
102 View
218 Download

Altmetric

Share

Gmail Facebook X LinkedIn More